Chicago, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Immunoassay market in terms of revenue was estimated to be worth $35.0 billion in 2023 and is poised to reach $46.7 billion by 2028, growing at a CAGR of 5.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The immunoassay market is driven by a rise in the geriatric population and the subsequent increase in the prevalence of chronic medical conditions and increasing adoption of immunoassay-based POC testing and rapid testing. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Immunoassay Market Scope: Report Coverage Details Market Revenue in 2023 $35.0 Billion Esti
